Litigation

Recent Posts

High Court: Investors Properly Pleaded Materiality In Securities Class Action Suit
Posted on 23 Mar 2011 by Timothy Raub

WASHINGTON, D.C. - (Mealey's) The U.S. Supreme Court on March 22 unanimously affirmed that shareholders of a drug maker properly showed that the drug maker violated federal securities law by failing to disclose that one of its products caused adverse... Read More

Sanofi Loses Cancer Drug Patent Fight In Delaware
Posted on 28 Sep 2010 by LexisNexis Litigation Resource Community Staff

WILMINGTON, Del. - (AP) A federal judge in Delaware has ruled against French drug maker Sanofi-Aventis SA in a patent dispute involving its cancer drug Taxotere. Full version available to lexis.com subscribers . Read More

Glaxo Settles Bad Drug Claim For More Than $40 Million
Posted on 24 Jun 2011 by LexisNexis Litigation Resource Community Staff

PROVIDENCE, R.I. - (AP) The American subsidiary of a major British drug maker, GlaxoSmithKline LLC, has agreed to pay more than $40 million to 37 states and Washington, D.C., to settle complaints alleging manufacturing process issues at a now-shuttered... Read More